Neuron - GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a ClC-2 Cl− Channel Auxiliary Subunit

Neuron - GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a ClC-2 Cl− Channel Auxiliary Subunit

GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a ClC-2 Cl⁻ Channel Auxiliary Subunit

• Summary
• Introduction
• Results
• Discussion
• Exp. Proc.
• Data
• References
• Supp. Info.
• Related Info.
• Comments (0)

• Video Abstract

Download this Video (16.14 MB)

• PDF 1.87 MB
• Export Citation
• Permissions

Neuron, Volume 73, Issue 5, 951-961, 8 March 2012
Copyright © 2012 Elsevier Inc. All rights reserved.
10.1016/j.neuron.2011.12.039

Refers to: Biochemistry to the Rescue: A ClC-2 Auxi...

Authors

Elena Jeworutzki, Tania López-Hernández, Xavier Capdevila-Nortes, Sònia Sirisi, Luiza Bengtsson, Marisol Montolio, Giovanni Zifarelli, Tanit Arnedo, Catrin S. Müller, Uwe Schulte, Virginia Nunes, Albert Martínez, Thomas J. Jentsch, Xavier Gasull, Michael Pusch, Raúl EstévezSee Affiliations

• Highlights
• GlialCAM, which is defective in MLC disease, is a ClC-2 Cl⁻ channel subunit
• GlialCAM modifies the targeting and the functional activity of the ClC-2 channel
• Mutations found in GLIALCAM in MLC affect the targeting of ClC-2 to cell junctions

Summary

Ion fluxes mediated by glial cells are required for several physiological processes such as fluid homeostasis or the maintenance of low extracellular potassium during high neuronal activity. In mice, the disruption of the Cl⁻ channel ClC-2 causes fluid accumulation leading to myelin vacuolation. A similar vacuolation phenotype is detected in humans affected with megalencephalic leukoencephalopathy with subcortical cysts (MLC), a leukodystrophy which is caused by mutations in MLC1 or GLIALCAM. We here identify GlialCAM as a ClC-2 binding partner. GlialCAM and ClC-2 colocalize in Bergmann glia, in astrocyte-astrocyte junctions at astrocytic endfeet around blood vessels, and in myelinated fiber tracts. GlialCAM targets ClC-2 to cell junctions, increases ClC-2 mediated currents, and changes its functional properties. Disease-causing GLIALCAM mutations abolish the targeting of the channel to cell junctions. This work describes the first auxiliary subunit of ClC-2 and suggests that ClC-2 may play a role in the pathology of MLC disease.